Profile for Adamas Pharmaceuticals, Inc. (ADMS)
« Back to company indexADMS Chatter Timeline
Stock Ticker for ADMS
Most Active Tweeters for ADMS
| User | Tweets |
|---|---|
| @CFinancialNews | 11 |
| @intercooleronli | 10 |
| @TheMarketsDaily | 7 |
| @storminvestor | 6 |
| @TickerReport | 6 |
Recent Tweets for ADMS
 |
@tradeRussian $ADMS may pop lil with pipers new pt of $30 September 25th 2017, 9:09am |
 |
@dailymailtimes Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/khnEvJTKsj September 25th 2017, 4:09am |
 |
@midetimes Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/pU0TJhWJ4a September 25th 2017, 4:09am |
 |
@dailypoliticaln Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/4aL3PxeJjN September 25th 2017, 4:09am |
 |
@WKRBNews Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/REVx09kXJQ September 25th 2017, 4:09am |
 |
@SleekMoneycom Adamas Pharmaceuticals $ADMS Given Daily Media Sentiment Rating of 0.22 https://t.co/AErpMGg0IA September 24th 2017, 4:09pm |
 |
@Neon68 @johnscharts i hate this, had the same with $ADMS September 24th 2017, 12:09pm |
 |
@TheMarketsDaily Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/rTbEnpI4mv September 24th 2017, 7:09am |
 |
@IRAMarketReport Adamas Pharmaceuticals, Inc. $ADMS Stock Rating Reaffirmed by Piper Jaffray Companies https://t.co/v3DMyyancB September 24th 2017, 5:09am |
 |
@chaffeybreeze Adamas Pharmaceuticals, Inc. $ADMS Stock Rating Reaffirmed by Piper Jaffray Companies https://t.co/c8etAMJmUC September 24th 2017, 5:09am |
 |
@TickerReport Adamas Pharmaceuticals, Inc. to Post Q3 2017 Earnings of -$0.93 Per Share, William Blair Forecasts $ADMS https://t.co/6E7h8P9mHm September 24th 2017, 1:09am |
 |
@emq_news Adamas Pharmaceuticals, Inc. to Post Q3 2017 Earnings of -$0.93 Per Share, William Blair Forecasts $ADMS https://t.co/7xL59cBlVX September 24th 2017, 1:09am |
|
@TickerReport Adamas Pharmaceuticals, Inc. to Post Q3 2017 Earnings of -$0.93 Per Share, William Blair Forecasts $ADMS https://t.co/VipKRnuLul September 24th 2017, 1:09am |
|
@TheMarketsDaily Adamas Pharmaceuticals, Inc. $ADMS Earns “Overweight” Rating from Piper Jaffray Companies https://t.co/zeW7I4XXKN September 23rd 2017, 9:09am |
 |
@TranscriptDaily William Blair Brokers Boost Earnings Estimates for Adamas Pharmaceuticals, Inc. $ADMS https://t.co/Nin12Ky2DT September 23rd 2017, 2:09am |
 |
@WatchlistN Adamas Pharmaceuticals, Inc. $ADMS Rating Increased to Hold at Zacks Investment Research https://t.co/IIHaRo1MBc September 23rd 2017, 2:09am |
 |
@QLFilings $ADMS filed Form 3 with the SEC. Most mentioned words: undersigned, attorney-in-fact, power, option, exchange September 22nd 2017, 6:09pm |
 |
@StockTexts $ADMS Adamas Pharmaceuticals, Inc. SEC Filing: Form 3 https://t.co/tMe6oUvTU8 September 22nd 2017, 5:09pm |
 |
@filingBot @KungPace there is a new form 3 filing for $ADMS https://t.co/MOnLnpsbH9 Tell the world! September 22nd 2017, 5:09pm |
 |
@SPNewsAnalysis Adamas Pharmaceuticals, Inc. $ADMS Upgraded to “Hold” at Zacks Investment Research https://t.co/ZwjoVpu9Rw September 22nd 2017, 2:09pm |
 |
@storminvestor Adamas Pharmaceuticals, Inc. $ADMS Upgraded to “Hold” at Zacks Investment Research https://t.co/BusUBkFrJP September 22nd 2017, 2:09pm |
|
@TickerReport Adamas Pharmaceuticals, Inc. $ADMS Forecasted to Earn FY2020 Earnings of $3.62 Per Share https://t.co/mLzGXs3jub September 22nd 2017, 1:09pm |
|
@TickerReport Adamas Pharmaceuticals, Inc. $ADMS Forecasted to Earn FY2020 Earnings of $3.62 Per Share https://t.co/vVINNphuXx September 22nd 2017, 1:09pm |
|
@emq_news Adamas Pharmaceuticals, Inc. $ADMS Forecasted to Earn FY2020 Earnings of $3.62 Per Share https://t.co/S9jfoLpC5B September 22nd 2017, 1:09pm |
|
@chaffeybreeze Adamas Pharmaceuticals, Inc. $ADMS Earns Buy Rating from Mizuho https://t.co/rMij54LAqV September 22nd 2017, 9:09am |
|
@IRAMarketReport Adamas Pharmaceuticals, Inc. $ADMS Earns Buy Rating from Mizuho https://t.co/CXhU5lw6LC September 22nd 2017, 9:09am |
|
@WatchlistN Adamas Pharmaceuticals, Inc. $ADMS Rating Reiterated by Piper Jaffray Companies https://t.co/S99EIILLvN September 22nd 2017, 7:09am |
 |
@CFinancialNews William Blair Brokers Lift Earnings Estimates for Adamas Pharmaceuticals, Inc. $ADMS https://t.co/0G60peZ7qY September 22nd 2017, 7:09am |
 |
@intercooleronli William Blair Brokers Lift Earnings Estimates for Adamas Pharmaceuticals, Inc. $ADMS https://t.co/MuCHsxHwFC September 22nd 2017, 6:09am |
 |
@NewsToDesk $ADMS: Daily Technical Summary Reports on Generic Drugs Stocks …: https://t.co/1ySy4qKWir September 22nd 2017, 6:09am |
 |
@ZolmaxNews Zacks Investment Research Upgrades Adamas Pharmaceuticals, Inc. $ADMS to “Hold” https://t.co/1MSyew05TV September 21st 2017, 8:09pm |
|
@CFinancialNews Adamas Pharmaceuticals, Inc. $ADMS Lifted to Hold at Zacks Investment Research https://t.co/D5Tk0TwQjZ September 21st 2017, 8:09pm |
|
@ZolmaxNews Zacks Investment Research Upgrades Adamas Pharmaceuticals, Inc. $ADMS to “Hold” https://t.co/1MSyewhGLt September 21st 2017, 8:09pm |
|
@intercooleronli Adamas Pharmaceuticals, Inc. $ADMS Lifted to Hold at Zacks Investment Research https://t.co/Yhu1cn6CWm September 21st 2017, 8:09pm |
|
@SleekMoneycom Zacks Investment Research Upgrades Adamas Pharmaceuticals, Inc. $ADMS to “Hold” https://t.co/RFRHslTWwi September 21st 2017, 8:09pm |
 |
@RatingsNetwork Adamas Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/QzhSQ63szr $ADMS #ADMS September 21st 2017, 8:09pm |
|
@WatchlistN Analysts Set Adamas Pharmaceuticals, Inc. $ADMS PT at $36.00 https://t.co/gYNehJEzoV September 21st 2017, 6:09pm |
 |
@confcalltran Departure of Directors or Certain https://t.co/ldfDOBQEDH $ADMS September 21st 2017, 4:09pm |
|
@filingBot @KungPace there is a new form 8-K filing for $ADMS https://t.co/uDEUsdZq07 Fav if you like. September 21st 2017, 4:09pm |
|
@TheMarketsDaily William Blair Weighs in on Adamas Pharmaceuticals, Inc.’s FY2020 Earnings $ADMS https://t.co/dBMsL2u4YN September 21st 2017, 4:09pm |
|
@CFinancialNews William Blair Weighs in on Adamas Pharmaceuticals, Inc.’s FY2020 Earnings $ADMS https://t.co/qtWeqN79AL September 21st 2017, 4:09pm |
|
@intercooleronli William Blair Weighs in on Adamas Pharmaceuticals, Inc.’s FY2020 Earnings $ADMS https://t.co/NnVC2UZpfW September 21st 2017, 3:09pm |
|
@SPNewsAnalysis Adamas Pharmaceuticals, Inc. $ADMS Receives Overweight Rating from Piper Jaffray Companies https://t.co/HvSDdmZWZe September 21st 2017, 12:09pm |
|
@storminvestor Adamas Pharmaceuticals, Inc. $ADMS Receives Overweight Rating from Piper Jaffray Companies https://t.co/NUwyt2vZpJ September 21st 2017, 12:09pm |
 |
@Bonsai_Me $ENDP $ADMS Adamas Releases Pricing For GOCOVRI https://t.co/5JiQ0aPXaT September 21st 2017, 10:09am |
|
@TranscriptDaily Adamas Pharmaceuticals, Inc. $ADMS Rating Reiterated by Mizuho https://t.co/dSecOuPtyX September 21st 2017, 6:09am |
|
@dailymailtimes Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/Zz6tSoR5Ql September 21st 2017, 1:09am |
|
@WKRBNews Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/ayxC8SMz2X September 21st 2017, 1:09am |
|
@midetimes Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/HPLGBdcrYn September 21st 2017, 1:09am |
|
@dailypoliticaln Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/ystDBudNRq September 21st 2017, 1:09am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.